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Abstract
Aims/hypothesis. The transcription factor Pdx1 is re-
quired for the development and differentiation of all
pancreatic cells. Beta-cell specific inactivation of
Pdx1 in developing or adult mice leads to an increase
in glucagon-expressing cells, suggesting that absence
of Pdx1could favour glucagon gene expression by a
default mechanism.
Method. We investigated the inhibitory role of Pdx1
on glucagon gene expression in vitro. The glucagono-
ma cell line InR1G9 was transduced with a Pdx1-
encoding lentiviral vector and insulin and glucagon
mRNA levels were analysed by northern blot and real-
time PCR. To understand the mechanism by which
Pdx1 inhibits glucagon gene expression, we studied its
effect on glucagon promoter activity in non-islet cells
using transient transfections and gel-shift analysis.
Results. In glucagonoma cells transduced with a Pdx1-
encoding lentiviral vector, insulin gene expression was
induced while glucagon mRNA levels were reduced by
50 to 60%. In the heterologous cell line BHK-21, Pdx1
inhibited by 60 to 80% the activation of the α-cell spe-
cific element G1 conferred by Pax-6 and/or Cdx-2/3.
Although Pdx1 could bind three AT-rich motifs within
G1, two of which are binding sites for Pax-6 and 
Cdx-2/3, the affinity of Pdx1 for G1 was much lower
as compared to Pax-6. In addition, Pdx1 inhibited Pax-
6 mediated activation through G3, to which Pdx1 was
unable to bind. Moreover, a mutation impairing DNA
binding of Pdx1 had no effect on its inhibition on 
Cdx-2/3. Since Pdx1 interacts directly with Pax-6 and
Cdx-2/3 forming heterodimers, we suggest that Pdx1
inhibits glucagon gene transcription through protein to
protein interactions with Pax-6 and Cdx-2/3.
Conclusion/interpretation. Cell-specific expression of
the glucagon gene can only occur when Pdx1 expres-
sion extinguishes from the early α cell precursor.
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num. Determination of the pancreatic fate of the dor-
sal anlage requires signals from the notochord repress-
ing endodermal Sonic hedgehog expression, whereas
the ventral anlage forms independently from the noto-
chord [1, 2]. In the mouse, the first two transcription
factors expressed in the prospective pancreatic endo-
derm are HB9 and Pdx1, which are detected at the 8 to
10 somite stage, respectively (embryonic day (E)
8–8.5) [3, 4, 5]; both factors are transiently expressed
in the entire pancreatic anlage and are crucial for its
development. Mice deficient in HB9 selectively lack
the dorsal pancreas due to a defect in specification of
the pancreatic epithelium, whereas the ventral pancre-
as develops and exhibits more subtle defects in beta-
cell differentiation and islet organization [3, 4]. Inacti-
The mammalian pancreas arises as two evaginations,
the dorsal and ventral pancreatic anlage, from the em-
bryonic endoderm in the region of the future duode-
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vation of Pdx1 results in pancreatic agenesis through a
failure in proliferation of the pancreatic epithelium as
well as in the branching and differentiation of the pan-
creatic buds [5, 6]. The widespread expression of HB9
and Pdx1 in the embryonic pancreas declines at
E9.5–10.5 (HB9) and E10.5 (Pdx1) and they are later
restricted to beta cells (HB9) or beta and δ cells
(Pdx1). Similarly, the homeobox gene Isl-1 is tran-
siently expressed in the entire dorsal bud and later re-
stricted to pancreatic endocrine cells; mice deficient in
Isl-1 lack the dorsal exocrine pancreas and have no
differentiated islet cells [7, 8, 9]. Another transcription
factor expressed very early (E9) during development
in discrete cells of the pancreatic epithelium is Pax-6,
a member of the paired-homeobox family. Pax-6 is
crucial for the differentiation of glucagon-producing 
α cells inasmuch as Pax-6 homozygous mutant mice
have no or few α cells [10, 11]. In contrast, inacti-
vation of Pax-4, another paired homeobox gene, re-
sults in the selective lack of beta and δ cells; mice
lacking both Pax-6 and Pax-4 have no endocrine cells
[12].
Several lines of evidence suggest that Pdx1 plays a
key role not only in islet cell differentiation but also in
maintaining the differentiated state and control of is-
let-hormone gene expression. Pdx1 is a major transac-
tivator of the insulin and somatostatin genes through
its synergistic interaction with E47/Beta2 and Pax6 or
Pbx/Prep1, respectively [13, 14, 15, 16, 17, 18]. Beta-
cell specific inactivation of Pdx1 in developing mice
resulted in a decrease in beta-cells with a concomitant
2.5-fold increase in Glu+ cells and to coexpression of
insulin and glucagon in 22% of cells suggesting that
α-cell differentiation and glucagon gene expression
are favored by the absence of Pdx1 in vivo [19]. Fur-
thermore, transient inhibition of Pdx1 in pancreatic
beta cells of adult mice by antisense RNA expression
using a Tet-On system led to reduction of Pdx1 depen-
dent beta-cell specific gene expression and to a strik-
ing increase in the number of glucagon gene express-
ing cells that were homogeneously distributed within
the islet [20]. Similarly, we could recently show in 
a Tet-On system in insulinoma cells that functional 
inactivation of Pdx1 resulted in differentiation of 
insulin-producing beta cells into glucagon-producing
α-cells [21].
In this work, we aimed to complement the studies
of Pdx1 function in beta cells by analysing the effect
of ectopic Pdx1 expression in α cells. Since α-cell
specificity is mainly characterized by glucagon gene
expression, we studied Pdx1 effects on glucagon gene
transcription in glucagonoma (InR1G9) cells by
Lentiviral transduction and on glucagon promoter ac-
tivity in non-islet cells. We show a new potential
function of Pdx1 as mediator of cell-specific expres-
sion of the glucagon gene through inhibition of tran-
scription.
Materials and methods
Cell culture and DNA transfection. The glucagon-producing
hamster InRIG9 [22] and mouse αTC1 [23], the insulin-pro-
ducing hamster HIT-T15 [24], the non-islet Syrian baby ham-
ster kidney (BHK-21) and human embryonic kidney (HEK)
cell lines were grown in RPMI 1640 (Seromed; Basel, Switzer-
land) supplemented with 5% heat-inactivated fetal calf serum
and 5% heat-inactivated newborn calf serum, 2 mmol/l gluta-
mine, 100 units/ml of penicillin, and 100 µg/ml of streptomy-
cin. BHK-21 and HEK cells were transfected by the calcium
phosphate precipitation technique [25] using 10–15 µg of total
plasmid DNA per 10-cm petri dish. One µg of pSV2A PAP, a
plasmid containing the human placental alkaline phosphatase
gene, driven by the simian virus 40 (SV40) early promoter was
added to monitor transfection efficiency [26]. Transfection of
InR1G9 cells was done using the DEAE-dextran method as 
described previously [27]. cDNAs for the hamster Cdx-2/3 and
Pdx1 (M.S. German, University of California, San Francisco,
Calif., USA), rat Isl-1 (D. Drucker, University of Toronto, 
Toronto, Canada), mouse Meis2 (N. Copeland, National Can-
cer Institute, Fredrick, USA), and quail Pax-6 (S. Saule, Insti-
tut Curie, Orsay, France), were cloned in the expression vector
pSG5 (Stratagene). In experiments using variable quantities of
expression vectors coding for Pdx1, Pax-6, or Cdx-2/3, total
amount of DNA was kept constant by adding appropriate
amounts of the empty vector pSG5. Reporter plasmids consist-
ed of the CAT reporter gene driven by different fragments of
the rat glucagon gene promoter (-292GluCAT, -138GluCAT,
G3–138GluCAT, G3–31GluCAT [28] or the rat insulin I gene
promoter (-410InsCAT, comprising 410 bp of the 5’flanking
sequence and 49 bp of exon 1 and intron 1 of the rat insulin I
gene) [29]. Data are presented as fold stimulation of the CAT
activity obtained with the reporter plasmid alone and are the
means +/- SEM of at least three experiments.
Transduction of InR1G9 cells with a lentiviral vector encoding
hPDX1. A Human PDX1 cDNA (hPDX1), kindly provided by
V. Schwitzgebel (University Hospital Geneva, Geneva, Swit-
zerland), was subcloned into pBluescript (Stratagene) and then
inserted into an optimized HIV-based vector (pWPT, kindly
provided by M. Wiznerowicz, Faculty of Medecine, Geneva,
Switzerland), generating the pWPT-PDX transfer plasmid.
Map and sequence are available at http://www.medecine.un-
ige.ch/~salmon/pWPT-PDX.html. Stocks of pWPT-PDX lenti-
viral vectors were produced using transient cotransfection of
293T cells with pWPT-PDX, R8.91 (second generation HIV-
packaging plasmid [30], and pMDG (VSV envelope-expres-
sion plasmid) as described previously [31]. Vectors were con-
centrated by ultracentrifugation and resuspended in serum-free
medium (CellGro SCGM, CellGenix, Freiburg, Germany) as
described previously [32]. Vector stocks were stored at −70°C
and titres were determined by enzymatic assay of HIV reverse
transcriptase. For hPDX1 transduction, 3×104 INR1G9 cells
were transduced in 50 µl of RPMI 1640 10% FCS with
2.5×104 pPWT-PDX transducing units (as determined by RT
assay). After 24 h, cells were washed twice with RPMI 10%
FCS and cultured for further 72 h before testing for Pdx1 ex-
pression by immunocytochemistry using anti-Pdx1 antibodies
kindly provided by C. V. E. Wright (Vanderbilt Medical Cen-
ter, Nashville, Tenn., USA). RNA was isolated for northern
blotting using Trizol (Invitrogen) and whole-cell protein ex-
tracts were prepared for EMSA. Northern blots were sequen-
tially hybridized with random labelled complementary DNA
(cDNA) probes for rat glucagon and proinsulin I and an 18S 
ribosomal (rRNA) oligonucleotide probe (5′-GCCGTCCCTC-
TTAATCATGGCCTCAGTTCC). Hybridization signals of the
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pWPT-PDX transduced InR1G9 cells were quantified using a
PhosphoImager (Molecular Dynamics) and expressed as gluca-
gon mRNA/18S rRNA ratio relative to the control cells.
Quantitative RT-PCR. Reverse transcription was done by using
2 µg of total RNA isolated from HIT-T15 and from non-infect-
ed or lentivirus-infected InR1G9 cells, random hexanucleotide
primers and Superscript II reverse transcriptase (Invitrogen).
One tenth of the resulting cDNA was used for real-time PCR
in the LightCycler instrument (Roche) using the QuantiTect
SYBR Green PCR kit (Qiagen) as recommended by the pro-
vider. The following primers were used: insulin sense 5′-
tcttctacacacccaagacc, antisense 5′-gttccacaatgccacgcttc; gluca-
gon sense 5′-gatcattcccagcttcccag, antisense 5′-ctggtaaaggtcc-
cttcagc; 28S rRNA sense 5′-tagccaaatgcctcgtcatc, antisense 5′-
acctctcatgtctcttcacc.
Chloramphenicol aetyltransferase (CAT) and protein assays.
Cell extracts were prepared 48 h after transfection and analy-
sed for CAT and alkaline phosphatase activities as described
previously [28]. Quantification of acetylated and non-acetyla-
ted forms was done with a PhosphorImager (Molecular Dy-
namics). A minimum of three independent transfections was
done; each of them carried out in duplicate.
Electrophoretic Mobility Shift Assays (EMSAs). Nuclear ex-
tracts from InR1G9, HIT-T15 or BHK-21 cells transfected
with Pax-6 or Pdx1 expression plasmids or the empty vector
pSG5 were prepared according to [33]. EMSAs were carried
out as described previously [34] adding first 8 to 28 µg (8 µg in
standard reactions) of nuclear extracts and subsequently la-
belled oligonucleotides containing the rat glucagon gene G1
(G1–56, G1–52, G1–54, G1–50) or G3 (5′-GCTGAAGTA-
GTTTTTCACGCCTGACTGAGATTGAAGGGTGTATTTC)
sequence [35, 36], or the A3/A4 element of the rat insulin I
gene (InsA3/A4, 5′-GATCTTGTTAATAATCTAATTACCCT-
AGAACAATTATTAGATTAATGG) [37]. In competition ex-
periments, labelled and cold oligonucleotides were added
simulaneously and when specific antibodies were used, they
were added after half of the incubation time. Antisera were
generously provided by H. Edlund (anti-Pdx1; University of
Umea, Umea, Sweden), S. Saule (anti-Pax-6 homeodomain,
serum no. 13; Institut Curie, Orsay, France), D. Melloul (anti
full-length Pdx1; Hebrew University Hadassah Medical Cen-
ter, Jerusalem, Israel), and M.S. German (anti-Cdx-2/3; Uni-
versity of California, San Francisco, Calif., USA).
Mutagenesis of Pdx1. In vitro mutagenesis was done by using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene,
The Netherlands) according to the manufacturer’s protocol us-
ing the following primers for the I192Q mutation of Pdx1: for-
ward 5′-gagacacatcaagcagtggttccaaaacc and reverse 5′-ggttttg-
gaaccactgcttgatgtgtctc.
GST fusion proteins and GST-precipitation. Hamster Pax-6
GST fusion proteins have been described [36]. GST fusion
proteins were expressed in E. coli and purified according to the
manufacturer recommendations (Pharmacia). L-[35S]methio-
nine-labelled Pdx1 was generated in vitro using the TNT wheat
germ extract system (Promega) and GST-precipitations were
done as described previously [36].
Data analysis. Data are presented as means ± SE and statistical
significance was tested by analysis of variance and Student’s 
t test where applicable. The threshold for statistical signifi-
cance was a p value of less than 0.05 (* and ** indicate statis-
tical significance with p<0.05 and p<0.01, respectively).
Results
Lentiviral transduction of Pdx1 in InR1G9 cells inhibits
transcription of the endogenous glucagon gene. To as-
sess the effect of ectopic Pdx1 expression in glucagon-
producing cells, we transduced the hamster glucagono-
ma cell line InR1G9 with a lentiviral vector coding for
hPdx1. After 4 days, expression of Pdx1 in two inde-
pendent transductions of InR1G9 cells was confirmed
by immunocytochemistry and EMSA in 90% of the
cells (data not shown). Northern blot and real-time PCR
analysis showed that Pdx1 repressed endogenous gluca-
gon mRNA levels by 50% and induced the endogenous
insulin gene in the glucagonoma cell line (Fig. 1).
Pdx1 inhibits transcriptional activation of the gluca-
gon gene promoter by Pax-6 and Cdx-2/3. To investi-
gate the mechanisms by which Pdx1 decreases gluca-
gon mRNA levels, we analysed its effect on transacti-
vation of glucagon gene reporter constructs in the
non-islet cell line BHK-21. The paired-homeodomain
protein Pax-6, which is essential for the development
of α cells, acts as a major transactivator of the gluca-
gon gene by its interaction with the α-cell-specific
promoter element G1 and the enhancer G3 [10, 11,
36]. In addition, the homeodomain protein Cdx-2/3
transactivates the glucagon gene promoter indepen-
dently through G1 and acts synergistically with Pax-6
[36, 38]. Since Pdx1 has been reported to interact with
both Pax-6 and Cdx-2/3 in vitro [15, 38], we investi-
gated the effects of Pdx1 on Pax-6 and Cdx-2/3 
induced activation of glucagon gene promoter con-
structs. Overexpression of Pdx1 resulted in a dose-
dependent inhibition, up to 90%, of Pax-6 mediated
transcriptional stimulation whether G1 (-138GluCAT),
G3 (G3–31GluCAT), or both G1 and G3 (G3–138Glu-
CAT) were present in the reporter construct (Fig. 2).
Pdx1 is thus able to inhibit Pax-6 mediated activation
of glucagon gene expression through both the G1 and
G3 elements in BHK-21 cells. In addition to its inhibi-
tory action on Pax-6, Pdx1 reduced the Cdx-2/3 and
Pax6/Cdx-2/3-mediated activations of G1 (-138Glu-
CAT) by 65% and 85%, respectively (Fig. 2C). Con-
trol cotransfections with Isl-1 [39] and Meis2 [40] had
no effect on Pax-6 or Cdx-2/3 induced transcriptional
activation (Fig. 2C).
When Pdx1 was transfected in BHK-21 cells in the
absence of Pax-6 and Cdx-2/3, CAT activity driven by
-138Glu was stimulated (Fig. 2C, Fig. 3). This effect
was dose-dependent and quantitatively similar to the
activation observed with the rat insulin I promoter
construct -410InsCAT (Fig. 3). However, the maximal
4.6-fold stimulation of the glucagon gene promoter by
Pdx1 was weak when compared to that obtained with
Pax-6 or Pax6/Cdx-2/3.
Pdx1 binds to the G1 element. The G1 element of the
glucagon gene promoter contains three AT-rich se-
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quences, two of which form a nearly perfect direct re-
peat with binding sites for the homeodomain contain-
ing proteins Pax-6 and Cdx-2/3 (Fig. 4A) [35, 36, 38,
41]. Since Pdx1 is a member of the Antennapedia
family of homeodomain proteins [42] and able to
transactivate -138Glu in the absence of Pax-6 and
Cdx-2/3, we tested whether Pdx1 could bind to the
glucagon gene promoter. With glucagon-producing
InR1G9 cell extracts, at least three protein complexes
are formed on G1–56 comprising the direct repeat ele-
ment within G1; Pax-6 as a monomer, Pax-6/Cdx-2/3
as a heterodimer, and HNF3β [36, 43] (Fig. 4A,B,
G1–56). Using nuclear extracts from the insulin-pro-
ducing cell line HIT-T15, which contains Pdx1, an ad-
ditional complex was detected. This band co-migrated
with a complex formed in BHK-21 cells overexpress-
ing Pdx1 and was recognized by anti-Pdx1 antibodies.
Fig. 1A, B. Pdx1 induces insulin mRNA and reduces endoge-
nous glucagon mRNA levels in glucagonoma cells. Northern
blot (A) and Real-time RT-PCR (B) analysis of glucagon-pro-
ducing InR1G9 cells (contr. A, contr. B), from two experi-
ments of unselected InR1G9 cellpools transduced with a lenti-
viral vector coding for hPdx1 (Pdx1 A, Pdx1 B,), and Hit-T15
cells. The proportion of infected cells was roughly 90% (im-
munocytochemistry), but Pdx1 infected cellpool A showed a
slightly stronger Pdx1 protein complex in EMSA that cellpool
B. (A) Northern blot sequentially hybridized with probes for
insulin, glucagon and 18S rRNA. (B) Quantitative RT-PCR
showing that Pdx1 reduces glucagon mRNA levels to roughly
36% and 62% of wild-type levels (cellpool A and B, respec-
tively). Whereas insulin mRNA was undetectable in noninfect-
ed InR1G9 cells by Northern blot (A), quantitative RT-PCR
provided evidence of as little as 0.2% of insulin mRNA levels
found in HIT-T15 cells. Pdx1 infection increased insulin
mRNA levels by 21 and 27-fold reaching 4% and 6% (cellpool
A and B, respectively) of HIT-T15 insulin mRNA levels
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Pdx1 is thus able to interact with the G1 element. To
localize the binding site of Pdx1 within G1, we used
oligonucleotides G1–54, G1–52, and G1–50 repre-
senting the three AT-rich elements. Pdx1 bound to all
these sites (Fig. 4B) and is thus capable of interacting
with three AT-rich motifs within the first 100 bp of the
glucagon gene promoter.
Fig. 2A–C. Pdx1 interferes with transcriptional activation of
the glucagon gene promoter by Pax-6 and Cdx-2/3. (A) Sche-
matic representation of glucagon reporter gene constructs used
in this study. Characterized cis-acting control elements are des-
ignated as G1 to G4. (B) Dose-dependent inhibition of the
Pax-6-mediated activation of the glucagon gene elements G1
(-138GluCAT) and/or G3 by Pdx1 in BHK-21 cells. (C) To as-
sess their effect on Pax-6 and/or Cdx-2/3 mediated activation
of the glucagon gene promoter, BHK-21 cells were cotransfec-
ted with 1 µg of Pdx1, Pax-4, Meis2, and/or Isl-1 expression
vectors, 250 ng of expression vectors containing the Pax-6
and/or Cdx-2/3 cDNAs and 10 µg of -138GluCAT
Fig. 3. Dose-dependent activation of the glucagon gene ele-
ment G1 by Pdx1. BHK-21 cells were cotransfected with 10 µg
of the indicated reporter plasmids and increasing amounts of
Pdx1 expression vectors
To assess the relative affinity of Pdx1 for G1 com-
pared to the A3/A4 of the rat insulin I gene, a known
Pdx1 binding site, we carried out EMSA competition
experiments. A similar molar excess of cold G1–56
and InsA3/A4 oligonucleotides competed for the Pdx1
complex formed with InsA3/A4 indicating that Pdx1
binds to both elements with roughly the same affinity
(Fig. 4C). These data are in agreement with the equiv-
alent transactivation of the glucagon and insulin gene
promoters by Pdx1. When the individual glucagon
gene binding sites were used for EMSA, the most
proximal motif G1–50 displayed a slightly higher 
affinity for Pdx1 compared to G1–52 and G1–54 lo-
cated within G1–56 but lower compared to InsA3/A4
(Fig. 4D).
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Fig. 4A–D. Pdx1 binds to three sites within the glucagon gene
G1 element. (A) Schematic diagram illustrating oligonucleo-
tides for the glucagon gene G1 element and protein complexes
formed on G1. The AT-rich elements are underlined. (B) EMSA
using nuclear extracts from InR1G9, Hit-T15, or BHK-21 cells
overexpressing Pdx1. Pdx1 was able to bind the three AT-rich
elements contained within G1. Ab indicates the addition of anti-
Pdx1 antibodies. A and C represent yet unidentified protein-
DNA complexes.(C, D) Nuclear extracts of BHK-21 cells over-
expressing Pdx1 were incubated with the InsA3/A4 or G1–50
oligonucleotide and the indicated excess of cold competitor oli-
gonucleotides. Bold arrowheads and asterisks indicate specific
and non-specific complexes, respectively
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Fig. 5A–E. Pdx1 does not impair Pax-6 binding to the gluca-
gon gene promoter. (A, B) Competition experiments analysing
the relative affinity of Pdx1 and Pax-6 for the G1 element. Pro-
tein-DNA complexes formed with nuclear extracts from BHK-
21 cells overexpressing Pdx1, Pax-6 or Cdx-2/3 and G1–56
were competed for by the indicated molar excess of cold oligo-
nucleotides. (C) Pax-6 containing extracts from BHK-21 cells
were mixed with increasing amounts of Pdx1 containing ex-
tracts and incubated with the G3 oligonucleotide. No impair-
ment of Pax-6 binding by Pdx1 was observed. Heterodimers of
the widely expressed Prep1/Pbx proteins formed on G3 [44]
are observed in all BHK-21 extracts. (D) Pdx1 formed a het-
erodimer with Pax-6 on G1–56; this complex was displaced by
adding anti-Pax6 (P6) or anti-Pdx1 (P1) antibodies. The identi-
ty of two further slower migrating complexes containing Pdx1
has yet to be determined. (E) When Pdx1 containing extracts
were mixed with Cdx-2/3 containing extracts, Cdx-2/3 formed
a heterodimer with Pdx1 on G1-56; this complex was dis-
placed by adding anti-Cdx-2/3 antibodies. Note that when anti-
Pdx1 antibodies were used, the Cdx-2/3-Pdx1 heterodimer was
displaced and a Cdx-2/3 homodimer with only slightly slower
migration than Cdx-2/3-Pdx1 was formed
Pdx1 forms heterodimers with Pax-6 and Cdx-2/3 on
G1. To investigate the mechanism by which Pdx1 
affects the Pax-6 and Cdx-2/3 mediated activation of
the glucagon gene, we assessed whether Pdx1 could
affect Pax-6 and Cdx-2/3 binding to DNA in vitro.
When BHK-21 nuclear extracts containing Pax-6 were
mixed with Pdx-containing extracts, Pdx1 formed a
weaker complex on G1–56 as compared with the
binding reaction without Pax-6 (Fig. 5A). Further-
more, competition with cold G1–56 showed a better
affinity of Pax-6 compared with Pdx1 for G1. By con-
trast with Pax-6, Cdx-2/3 and Pdx1 displayed similar
affinity for G1–56 (Fig. 5B).
Alternatively to a mechanism of direct competition
for the binding site, Pdx1 could interact with Pax-6
and/or Cdx-2/3 and either form a heterodimer or im-
pair DNA binding by protein to protein interaction.
We therefore analysed the effect of adding various
amounts of Pdx1 on Pax-6 binding to G3 and G1.
Pdx1 overexpressed in BHK-21 cells did not interact
with G3, only heterodimers of the ubiquitous proteins
Pbx and Prep1 [44] were observed (Fig. 5C). Pax-6
formed a complex with G3 that was not affected by
the addition of increasing amounts of Pdx1-containing
extracts (Fig. 5C). In contrast to G3, Pdx1 bound as a
monomer and a homodimer to G1 (Fig. 5D). In addi-
tion, a Pax6:Pdx1 heterodimer was formed that was
recognized by both anti-Pdx1 and anti-Pax-6 antibod-
ies, thus confirming the protein to protein interaction
of both transcription factors (Fig. 5D). When Pdx1
and Cdx-2/3 containing extracts were mixed, both
proteins bound as monomers and Pdx1 did not impair
Cdx-2/3 binding. In addition, both proteins formed a
heterodimer that was recognized by anti-Cdx-2/3 and
anti-Pdx1 antibodies (Fig. 5E). Note that when anti-
Pdx1 antibodies were used, the Cdx-2/3-Pdx1 hetero-
dimer was displaced by a Cdx-2/3 homodimer with
only slightly slower migration than Cdx-2/3-Pdx1. We
therefore conclude that Pdx1 could exert its transcrip-
tional inhibition on the glucagon gene promoter
through protein to protein interaction with Pax-6 and
Cdx-2/3 that could change their conformation and in-
terfere with their transcriptional properties. Further-
more, inhibition of Pax-6 mediated activation could
also in part be mediated by competition of binding to
the G1 but not the G3 element.
Pdx1 interacts with the homeodomain of Pax-6. To test
for direct physical interactions of Pdx1 and Pax-6, we
did GST precipitation assays using GST fusion pro-
teins containing either the Pax-6 paired domain (PD),
homeodomain (HD) or paired-linker-homeodomain
(PDHD) and 35S-labelled Pdx1. Protein to protein in-
teractions with Pdx1 were observed with fusion pro-
teins comprising the Pax-6 HD (10% of the input),
whereas precipitation of Pdx1 with the Pax-6 PD was
weak. However, adding the PD and linker domain to
the Pax-6 HD increased interaction to 17% (Fig. 6).
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These data show that Pdx1 interacts with Pax-6 in the
absence of DNA and that major contacts are mediated
by the Pax-6 homeodomain although the linker domain
and/or PD might be required for full interactions.
Inhibition of Pax-6 and Cdx-2/3 mediated activation
is independent of Pdx1 DNA binding. To further test
our hypothesis that Pdx1 represses Pax-6 and Cdx-2/3
mediated activation of the glucagon gene promoter
through protein to protein interactions, we mutated
Pdx1 in an amino acid (I192Q) of the DNA recogni-
tion helix within the homeodomain that has been re-
ported to abolish binding to the A3/A4 element of the
rat insulin I gene promoter [45]. This mutant Pdx1
protein was produced at equivalent levels in fibroblast
cells and in in vitro translation assays (Fig. 7A), and
its binding activity to the G1 element was reduced by
more than 90% (Fig. 7B).
In cotransfection assays, a quantitatively similar re-
pression of Cdx-2/3 was observed with the Pdx1 wt
and mutant I192Q protein (Fig. 7C) confirming that
the inhibition of Cdx-2/3 mediated transcriptional ac-
tivation is independent of Pdx1 DNA binding and
rather occurs through protein to protein interactions.
In contrast, repression of Pax-6 mediated activation
was attenuated by the Pdx1 mutation (78% and 54%
Fig. 6A, B. Pdx1 interacts with the HD of Pax-6. (A) GST-pre-
cipitation assay using 10 µg of GST alone, GST-Pax-6 paired
(PD), homeo (HD) or paired-linker-homeodomain (PDHD, fu-
sion proteins immobilized on sepharose beads and in vitro syn-
thesized, 35S-labelled Pdx1. Lane input, 10% of the respective
in vitro translation reaction used for protein to protein interac-
tion. (B) Quantification of protein interactions shown in (A) as
the precipitation rates relative to the respective input. Data are
presented as the mean ± SEM of at least three experiments
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Fig. 7A–D. Mutant Pdx1 protein impaired in DNA binding
still repressed transcriptional activation of the glucagon gene
promoter by Pax6 and Cdx-2/3. (A) Western blot analysis
showing similar synthesis of wild-type (wt) and mutant
(I192Q) Pdx1 in HEK cells and in in vitro transcription/trans-
lation (TNT). (B) EMSA analysis showing 90% reduced bind-
ing activity of Pdx1 I192Q to G1 as compared to Pdx1 wt. (C)
To assess the effect of mutant Pdx1 on Pax-6 and Cdx-2/3 me-
diated activation of the glucagon gene promoter, BHK-21 cells
were cotransfected with 1 µg of wt Pdx or Pdx1 I192Q expres-
sion vectors and 250 ng of expression vectors containing the
Pax-6 or Cdx-2/3 cDNAs as well as 10 µg of -138GluCAT. (D)
GST-precipitation assay using 10 µg of GST alone or GST-
Pax-6 paired-linker-homeodomain fusion protein immobilized
on sepharose beads and in vitro synthesized, 35S-labelled Pdx1
wt or I192Q. Lanes input, 10% of the respective in vitro trans-
lation reactions used for protein to protein interaction
by wt and I192Q Pdx1, respectively). We therefore
tested by GST pulldown whether the I192Q mutation
affected interactions between Pdx1 and Pax-6. Protein
to protein interactions of both transcription factors
were reduced by approximately 65% indicating that
the Pdx1 homeodomain is critical for protein interac-
tions with Pax-6 (Fig. 7D). Since the reduced repres-
sor activity of Pdx1 I192Q on Pax-6 corresponds
quantitatively with the decreased protein to protein in-
teraction of both factors, we suggest that Pdx1 could
exert its repressor activity primarily through protein to
protein interaction. Our data cannot, however, rule out
a contribution of DNA binding competition to its in-
hibitory effect on Pax-6.
Discussion
We show that Pdx1 is able to act as a repressor of the
endogenous glucagon gene in InR1G9 glucagonoma
potentially neutralizing Cdx-2/3 function independent
of DNA binding. In the same study, Pdx1 was able to
inhibit the Cdx-2/3 mediated activation of the sucrose-
isomaltase gene in heterologous cells. (ii) Alternative-
ly, free Pdx1 might efficiently compete for common
coactivators and impair their interaction with DNA-
bound transcription factors thus blocking transcrip-
tional activation. In this regard it is interesting that
overexpression of Pdx1 in insulin-producing cells has
recently been shown to repress insulin promoter activ-
ity [50]. Similarly, an excess of Pdx1 impaired its syn-
ergy with E47 on the insulin mini-enhancer in non-is-
let cells [16]. One common cofactor linking specific
transcription factors to the basal transcription machin-
ery, CBP/p300, is able to physically interact with Pax-
6, Cdx-2/3, and Pdx1 [38, 51]. We therefore cotrans-
fected BHK-21 cells with increasing amounts of CBP
or p300; however, this complementation with tran-
scriptional coactivators failed to compensate for the
transcriptional repression by Pdx1. Pax-6 contains an
unusually long transactivation domain that has been
reported to directly interact with the TATA binding
protein within TFIID (TBP) [52]. Pdx1 could thus im-
pair Pax-6 interactions with TBP or alternatively, act
by disturbing a multifactorial transcription complex
by altering the ratio of its free components.
Pdx1 has been implicated in the tissue-specific acti-
vation of different genes through cell type and pro-
moter context dependent protein to protein interac-
tions. In acinar cells, Pdx1 associates with Pbx1 and
Meis2 on the B element of the elastase I gene [40] and
endocrine-specific complexes consist of Pdx1/Pbx,
Pdx1/Pax-6 or E47/Beta2/Pdx1 on the somatostatin
and insulin gene promoter, respectively [13, 14, 15,
16, 17]. These protein contacts allow for cooperative
DNA binding and synergistic transcriptional activa-
tion. We show a new potential function of Pdx1 as
mediator of cell-specific expression of the glucagon
gene through its inhibition of Pax-6 and Cdx-2/3 me-
diated transcription.
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